(S (NP (NP (DT The)
                      (NN amount))
                  (PP (IN of)
                      (NP (NP (NN blood))
                          (SBAR (WHNP (X 0))
                                (S (NP (JJ surgical)
                                           (NNS patients))
                                   (VP (MD can)
                                       (VP (VB donate)
                                           (CC and)
                                           (VB store)
                                           (NP (NN *T*-1))
                                           (PP (IN before)
                                                   (NP (NN surgery))))))))))
        (VP (MD can)
            (VP (VB be)
                (VP (VBN increased)
                    (NP (NN *-3))
                    (PP (IN by)
                        (NP (NP (DT the)
                                    (JJ new)
                                    (ADJP (RB genetically)
                                          (VBN engineered))
                                    (NN drug))
                                (, ,)
                                (NP (NNP EPO)))))))
        (. .))

(S (NP (NP (NNP EPO))
                (, ,)
                (CC or)
                (NP (NN erythropoietin))
                (, ,))
        (VP (VBZ is)
            (NP (NP (DT a)
                        (NN protein))
                    (SBAR (WHNP (X 0))
                          (S (NP (DT the)
                                       (JJ human)
                                       (NN body))
                             (VP (VBZ makes)
                                 (NP (NN *T*-1))
                                 (S (NP (NN *PRO*-2))
                                        (VP (TO to)
                                            (VP (VB stimulate)
                                                (NP (NP (DT the)
                                                        (NN growth))
                                                    (PP (IN of)
                                                        (NP (JJ red)
                                                            (NN blood)
                                                            (NNS cells))))))))))))
        (. .))

(S (NP (NP (NP (DT A)
                          (ADJP (RB genetically)
                                (VBN engineered))
                          (NN version))
                      (PP (IN of)
                          (NP (DT the)
                              (JJ human)
                              (NN protein))))
                  (VP (VBN developed)
                      (NP (NN *))
                      (PP (IN by)
                          (NP (NP (NNP Amgen)
                                      (NNP Corp.))
                                  (PP (IN of)
                                      (NP (NP (NNP Thousand)
                                              (NNP Oaks))
                                          (, ,)
                                          (NP (NNP Calif.))
                                          (, ,)))))))
        (ADVP (RB recently))
        (VP (VBZ has)
            (VP (VBN been)
                (VP (VBN marketed)
                    (NP (NN *-1))
                    (PP (IN by)
                        (NP (NP (DT the)
                                    (NML (NNP Ortho)
                                         (NNP Pharmaceuticals))
                                    (NN division))
                                (PP (IN of)
                                    (NP (NNP Johnson)
                                        (CC &)
                                        (NNP Johnson))))))))
        (. .))

(S (NP (NP (DT A)
                      (VBG competing)
                      (NN version))
                  (PP (IN of)
                      (NP (NNP EPO))))
        (VP (VBZ is)
            (VP (VBG being)
                (VP (VBN developed)
                    (NP (NN *-1))
                    (PP (IN by)
                        (NP (NP (NNP Genetics)
                                    (NNP Institute)
                                    (NNP Inc.))
                                (PP (IN in)
                                        (NP (NP (NNP Cambridge))
                                            (, ,)
                                            (NP (NNP Mass)))))))))
        (. .))

(S (NP (DT The)
                  (NN drug))
        (VP (VBZ is)
            (VP (VBG being)
                (VP (VBN used)
                    (NP (NN *-1))
                    (ADVP (RB primarily))
                    (S (NP (NN *PRO*))
                           (VP (TO to)
                               (VP (VB treat)
                                   (NP (NNS anemias))))))))
        (. .))

(S (NP (NP (DT A)
                    (JJ new)
                    (NN experiment))
                (, ,)
                (VP (VBN reported)
                    (NP (NN *))
                    (PP (IN in)
                            (NP (NP (NP (DT this)
                                        (NN week)
                                        (POS 's))
                                    (NML (NNP New)
                                         (NNP England))
                                    (NNP Journal))
                                (PP (IN of)
                                    (NP (NNP Medicine))))))
                (, ,))
        (VP (VBD involved)
            (S (NP (NN *PRO*))
               (VP (VBG giving)
                   (NP (NP (NNS injections))
                       (PP (IN of)
                           (NP (NP (NNP Amgen)
                                   (POS 's))
                               (NNP EPO))))
                   (PP (IN to)
                           (NP (NP (CD 23)
                                   (NNS patients))
                               (SBAR (WHNP (WP who))
                                     (S (NP (NN *T*-1))
                                        (VP (VBD wanted)
                                            (S (NP (NN *PRO*-2))
                                               (VP (TO to)
                                                   (VP (VB store)
                                                       (NP (NP (NNS units))
                                                           (PP (IN of)
                                                               (NP (PRP$ their)
                                                                   (JJ own)
                                                                   (NN blood)))))))))))))))
        (. .))

(S (NP (DT The)
                  (NNS patients))
        (VP (VBD began)
            (S (NP (NN *-1))
               (VP (VBG receiving)
                   (NP (NNP EPO)
                       (NNS injections))
                   (PP (NP (QP (IN about)
                                       (DT a))
                                   (NN month))
                           (IN before)
                           (NP (PRP$ their)
                               (VBN scheduled)
                               (NN surgery))))))
        (. .))

(S (NP (PRP They))
        (ADVP (RB then))
        (VP (VBD began)
            (S (NP (NN *-1))
               (VP (VBG donating)
                   (NP (NN blood))
                   (NP (PDT twice)
                           (DT a)
                           (NN week))
                   (, ,)
                   (S (NP (NN *PRO*-2))
                          (VP (VBG receiving)
                              (NP (DT an)
                                  (NNP EPO)
                                  (NN injection))
                              (NP (DT each)
                                      (NN time)))))))
        (. .))

(S (SBAR (IN If)
                  (S (NP (NNS tests))
                     (VP (VBD indicated)
                         (NP (NP (DT a)
                                 (JJ low)
                                 (NN number))
                             (PP (IN of)
                                 (NP (JJ red)
                                     (NNS cells)))))))
        (, ,)
        (NP (NN blood))
        (VP (VBD was)
            (RB n't)
            (VP (VBN taken)
                (NP (NN *-1))))
        (. .))

(S (NP (DT The)
                (ADJP (NNP EPO)
                      (HYPH -)
                      (VBN treated))
                (NNS patients))
        (VP (VBD donated)
            (NP (NP (DT an)
                    (NN average))
                (PP (IN of)
                    (NP (NP (CD 5.4)
                            (NNS units))
                        (PP (IN of)
                            (NP (NN blood)))))
                (NP (DT each)))
            (PP (VBN compared)
                (PP (IN with)
                    (NP (NP (QP (RB only)
                                (CD 4.1))
                            (NNS units))
                        (VP (VBN donated)
                            (NP (NN *))
                            (PP (IN by)
                                (NP (NP (DT a)
                                            (JJ similar)
                                            (NN group))
                                        (PP (IN of)
                                            (NP (NP (JJ surgical)
                                                    (NNS patients))
                                                (SBAR (WHNP (WP who))
                                                      (S (NP (NN *T*-1))
                                                         (VP (VBD received)
                                                             (NP (DT a)
                                                                 (NN placebo)
                                                                 (NN injection))))))))))))))
        (. .))

(S (S (NP (NP (DT The)
                             (NN volume))
                         (PP (IN of)
                             (NP (NP (JJ red)
                                     (NNS cells))
                                 (VP (VBN donated)
                                     (NP (NN *))
                                     (PP (IN by)
                                         (NP (DT the)
                                                 (ADJP (NNP EPO)
                                                       (HYPH -)
                                                       (VBN treated))
                                                 (NNS patients)))))))
                 (VP (VBD was)
                     (ADVP (NP (CD 41)
                                   (NN %))
                               (JJR higher))
                     (PP (IN per)
                         (NP (NN donor)))))
        (, ,)
        (NP (NP (DT the)
                    (NN research)
                    (NN team))
                (VP (VBG representing)
                    (NP (NP (DT a)
                            (NN number))
                        (PP (IN of)
                            (NP (NP (NNS hospitals))
                                (CC and)
                                (NP (NN blood)
                                    (NNS banks)))))))
        (VP (VBD reported)
            (SBAR (X 0)
                  (S (X *T*-1))))
        (. .))

